GENOTYPING AND POLYMORPHISMS OF THE CYP2C19 GENE IN PATIENTS WITH CHRONIC GASTRITIS

Authors

  • Alisher Kamilovich Ochilov Department of Pharmacology and Clinical Pharmacology Bukhara State Medical Institute, Uzbekistan

Keywords:

Genotyping, polymorphism, chronic gastritis, proton pump inhibitors, pharmacotherapy, polymorphic markers

Abstract

The article discusses the results of genotyping patients to improve the pharmacotherapy of acid-dependent diseases of the digestive system by the CYP2C19 gene, which provides the pharmacokinetics of drugs from the proton pump inhibitor group contributed to improving the effectiveness, safety and personalization of pharmacotherapy, which serves to improve the quality of life of patients.

Downloads

Published

2022-07-18

How to Cite

Ochilov, A. K. . (2022). GENOTYPING AND POLYMORPHISMS OF THE CYP2C19 GENE IN PATIENTS WITH CHRONIC GASTRITIS. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 2(7), 39–44. Retrieved from https://inovatus.es/index.php/ejmmp/article/view/1092

Issue

Vol. 2 No. 7 (2022): EJMMP

Section

Articles

Similar Articles

<< < 3 4 5 6 7 8 9 10 11 12 > >> 

You may also start an advanced similarity search for this article.